UCB's Cimzia has received Food & Drug Administration approval for treating Crohn's disease.
Crohn’s disease patients have a new monthly treatment option open to them. It’s UCB’s UCB claims Cimzia is the first and only PEGylated anti-tumor necrosis factor alpha antibody indicated for this
Psychiatric Pharmacist Working to Optimize Treatment, Improve Patient Safety
December 13th 2024A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.